NIAID Researchers Find Anti-HIV Antibodies Affect Immune Responses When Delivered During Acute Infection
Topics
Cross-posted from: National Institute of Allergy and Infectious DiseasesExit Disclaimer
National Institute of Allergy and Infectious Diseases (NIAID) scientists examined the effects of modified anti-HIV broadly neutralizing antibodies (bNAbs) that have an increased ability to bind to cells in the body at a region called the Fc receptor. When given during acute—or early—infection in a primate model of HIV, the bNAbs affected innate and adaptive cellular immune responses to the virus. According to the researchers, this could inform future HIV treatment strategies using bNAbs. The study was published in Nature Communications.